Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | VANGL1 |
| Upstream (Parents) |
|---|
| (<<) CYB5R3 → VANGL1 |
| (<<) CYP1A2 → VANGL1 |
| (<<) CYP27B1 → VANGL1 |
| (<<) EDN1 → VANGL1 |
| (<<) GPR153 → VANGL1 |
| (<<) IGFBP7 → VANGL1 |
| (<<) KRT5 → VANGL1 |
| (<<) LIF → VANGL1 |
| (<<) MAPK9 → VANGL1 |
| (<<) NFIB → VANGL1 |
| (<<) PDIA3 → VANGL1 |
| (<<) RASD1 → VANGL1 |
| (<<) RPA4 → VANGL1 |
| (<<) TARSL2 → VANGL1 |
| (<<) TTC9 → VANGL1 |
| Downstream (Children) |
|---|
| VANGL1 → CALML5 (>>) |
| VANGL1 → ENO3 (>>) |
| VANGL1 → FAM110C (>>) |
| VANGL1 → HIST3H3 (>>) |
| VANGL1 → MYCN (>>) |
| VANGL1 → PAK2 (>>) |
| VANGL1 → SOX8 (>>) |
